Expression of Concern: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial

Bibliographic Details
Main Author: Frontiers Editorial Office
Format: Article
Language:English
Published: Frontiers Media S.A. 2022-01-01
Series:Frontiers in Medicine
Online Access:https://www.frontiersin.org/articles/10.3389/fmed.2021.831449/full
_version_ 1818255610248953856
author Frontiers Editorial Office
author_facet Frontiers Editorial Office
author_sort Frontiers Editorial Office
collection DOAJ
first_indexed 2024-12-12T17:14:36Z
format Article
id doaj.art-4dd45b4a3f644d98af22bff89e097794
institution Directory Open Access Journal
issn 2296-858X
language English
last_indexed 2024-12-12T17:14:36Z
publishDate 2022-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Medicine
spelling doaj.art-4dd45b4a3f644d98af22bff89e0977942022-12-22T00:17:49ZengFrontiers Media S.A.Frontiers in Medicine2296-858X2022-01-01810.3389/fmed.2021.831449831449Expression of Concern: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled TrialFrontiers Editorial Officehttps://www.frontiersin.org/articles/10.3389/fmed.2021.831449/full
spellingShingle Frontiers Editorial Office
Expression of Concern: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
Frontiers in Medicine
title Expression of Concern: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
title_full Expression of Concern: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
title_fullStr Expression of Concern: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
title_full_unstemmed Expression of Concern: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
title_short Expression of Concern: Proxalutamide Reduces the Rate of Hospitalization for COVID-19 Male Outpatients: A Randomized Double-Blinded Placebo-Controlled Trial
title_sort expression of concern proxalutamide reduces the rate of hospitalization for covid 19 male outpatients a randomized double blinded placebo controlled trial
url https://www.frontiersin.org/articles/10.3389/fmed.2021.831449/full
work_keys_str_mv AT frontierseditorialoffice expressionofconcernproxalutamidereducestherateofhospitalizationforcovid19maleoutpatientsarandomizeddoubleblindedplacebocontrolledtrial